Dr Agarwals Health Care Ltd

Dr Agarwal's Hea Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Dr Agarwals Health Care Ltd

₹ 455 2.48%
19 Sep - close price
dragarwals.co.in BSE: 544350 NSE: AGARWALEYE
About

Incorporated in 2010,[1]Dr. Agarwal’s Health Care offers a wide array of eye care services, which include cataract and refractive surgeries, consultations, diagnoses, and non-surgical treatments. Additionally, they provide optical products, contact lenses, accessories, and pharmaceutical items related to eye care. [2]

Key Points

Largest Eyecare Service Provider[1]
Dr. Agarwal is India's largest eye care service chain with a 25% market share. It is the largest company by revenue in FY23, with more than two times the revenue from operations of the second-largest eye care service chain in the country.

Website BSE NSE
  • Market Cap ₹ 14,387 Cr.
  • Current Price ₹ 455
  • High / Low ₹ 494 / 327
  • Stock P/E 140
  • Book Value ₹ 59.1
  • Dividend Yield 0.00 %
  • ROCE 9.99 %
  • ROE 4.76 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has delivered good profit growth of 41.7% CAGR over last 5 years

Cons

  • Stock is trading at 7.70 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 7.83% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare BSE SmallCap BSE IPO BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
333 349 403 417 431 460 487
244 241 300 310 316 329 360
Operating Profit 89 108 104 107 115 131 128
OPM % 27% 31% 26% 26% 27% 28% 26%
12 20 6 12 13 13 13
Interest 22 27 27 28 28 25 25
Depreciation 43 47 56 57 58 60 63
Profit before tax 36 54 27 33 41 59 54
Tax % 37% 24% 33% 36% 31% 27% 29%
23 41 18 21 28 43 38
EPS in Rs 0.72 1.03 0.95
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
531 471 696 1,018 1,332 1,711 1,795
407 387 510 743 965 1,248 1,314
Operating Profit 124 85 186 275 367 463 481
OPM % 23% 18% 27% 27% 28% 27% 27%
13 6 17 14 44 43 51
Interest 54 44 49 76 101 115 106
Depreciation 93 95 98 128 170 231 239
Profit before tax -11 -48 57 84 141 160 186
Tax % 82% 21% 24% -24% 32% 31%
-21 -59 43 103 95 110 130
EPS in Rs 2.64
Dividend Payout % 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 26%
3 Years: 35%
TTM: 28%
Compounded Profit Growth
10 Years: %
5 Years: 42%
3 Years: 26%
TTM: 12%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 6%
3 Years: 8%
Last Year: 5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 7 7 7 8 9 32
Reserves 242 177 206 622 1,330 1,835
162 185 633 857 966 961
339 417 179 336 445 837
Total Liabilities 751 787 1,025 1,823 2,751 3,665
551 575 701 1,293 1,746 2,523
CWIP 8 11 28 99 118 153
Investments 1 0 0 34 471 264
192 201 295 397 416 724
Total Assets 751 787 1,025 1,823 2,751 3,665

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
103 99 164 233 346 360
-85 -46 -155 -509 -914 -750
-73 -37 35 303 553 382
Net Cash Flow -56 17 44 27 -15 -8

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 36 36 30 27 27 26
Inventory Days 178 169 144 116 138 181
Days Payable 340 452 389 326 355 345
Cash Conversion Cycle -126 -247 -215 -183 -190 -138
Working Capital Days -31 -47 -50 -62 -65 -44
ROCE % -1% 17% 13% 11% 10%

Shareholding Pattern

Numbers in percentages

7 Recently
Mar 2025Jun 2025
32.45% 32.43%
60.62% 59.26%
5.21% 6.44%
1.74% 1.87%
No. of Shareholders 68,69663,021

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls